Open study to evaluate the efficacy and tolerance of imiquimod 5% cream for the treatment of a large and/or multiple superficial basal cell carcinoma.
Phase of Trial: Phase III
Latest Information Update: 25 Sep 2008
At a glance
- Drugs Imiquimod (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 25 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Sep 2008 Actual patient number (111) added as reported by ClinicalTrials.gov.
- 25 Sep 2008 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.